Protective effect of deferoxamine on sodium nitroprusside induced apoptosis in PC12 cells

Neuroscience Letters

Volumn 247, Issue 1, 1998, Pages 1-4

  Desole, M S ^a   Sciola, L ^a   Sircana, S ^a   Godani, C ^a   Migheli, R ^a   Delogu, M R ^a   Piras, G ^a   De Natale, G ^a   Miele, E ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Apoptosis; Defaroxamine; Iron release; PC12 cells; Sodium nitroprusside

Indexed keywords

DEFEROXAMINE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IRON KINETICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DEFEROXAMINE; NITROPRUSSIDE; PC12 CELLS; RATS;

EID: 0032496083     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00260-2     Document Type: Article

References (17)

1. Albina J.E., Cui S., Nateo B.B., Reichner S. Nitric-oxide mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:1993;5080-5085.
2. Blanco F.J., Ochs R.L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146:1995;75-85.
3. Dawson V.L., Dawson T.M. Nitric oxide actions in neurochemistry. Neurochem. Int. 29:1996;97-110.
4. Desole M.S., Sciola L., Delogu M.R., Sircana S., Migheli R. Manganese and 1-methyl-4-(2′-ethylphenyl)1,2,3,6-tetrahydropyridine induce apoptosis in PC12 cells. Neurosci. Lett. 209:1996;193-196.
5. Desole H.S., Sciola L., Delogu M.R., Sircana S., Nigheli R., Miele B. Manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC12 cells: role of oxidative stress. Neurochem. Int. 31:1997;169-176.
6. Garthwaite J., Boultom C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-686.
7. Gavrieli T., Sherman T., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell. Biol. 119:1991;493-501.
8. Halliwell B., Gutteridge J.M.C., Cross C.E. Free radicals, antioxidant and human disease: where are we now? J. Lab. Clin. Med. 119:1992;598-620.
9. Hartley A., Stone J.N., Heron C., Cooper J.N., Schapira A.H.V. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63:1994;1987-1990.
10. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived relaxing factor. Annu. Rev. Pharmacol. 30:1990;535-560.
11. Lancaster J.R., Hibbs J.B. Demonstration of iron-nitrosyl complex by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA. 87:1990;1223-1227.
12. Moncada S., Radomsky M.W., Palmer R.M.J. Nitric oxide. Biochem. Pharmacol. 37:1988;2495-2501.
13. Mosman T. Rapid colorimetric assay for cellular growth and survival app1ication to proliferation and cytotoxic assays. J. Immunol. Meth. 65:1983;55-63.
14. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
15. Reif D.W., Simmons R.D. Nitric oxide mediates iron release from ferritin. Arch. Biochem. Biophys. 283:1990;537-541.
16. 2+: their relationship to apoptosis and oncogenesis. FEBS Lett. 324:1993;104-107.
17. Youdim M.B.H., Ben-Shachar D., Eshel G., Finterg J.P.M., Risderer P. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease. Adv. Neurol. 60:1993;259-266.